People · Operator
Named in public records as an officer, director or promoter · active 2011–2023 · Biotechnology, Other Technology, Pharmaceuticals, AI / ML, Crypto / Web3, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tmunity Therapeutics, Inc. | — | Biotechnology | Series C | $175.0M | $3.1B | 2019 |
| SigmaSense, LLC | — | Other Technology | Series B | $111.0M | $74.6M | 2016 |
| Sancilio & Company, Inc. | — | Pharmaceuticals | Series B | $22.3M | $680.1M | 2012 |
| Generative AI Solutions Corp. | — | AI / ML | Series A | $11.3M | $2.2M | 2021 |
| Mega Blockchain Corp. | — | Crypto / Web3 | Series A | $7.7M | $257.2M | 2017 |
| Sancilio Pharmaceuticals Company, Inc. | — | Pharmaceuticals | Series A | $5.0M | $154.9M | 2018 |
| Revitalist Lifestyle & Wellness Ltd. | — | Healthtech | Seed | $3.8M | $56.3M | 2021 |
| HashChain Technology Inc. | — | Software / Tech | Seed | $2.5M | $68.1M | 2018 |
| Move That Block, LLC | — | Other Technology | Seed | $1.1M | $35.8M | 2011 |
| Exponential Genomics Inc. | — | Biotech | Pre-Seed | $600K | $33.1M | 2020 |
Patrick Gray at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick Gray on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Ciullo | 3 | 4 |
| Aaron Bowden | 3 | 4 |
| Dennis Langer | 2 | 9 |
| Frederick Sancilio | 2 | 4 |
| Haileab Samuel | 2 | 2 |
| Zyshan Kaba | 2 | 2 |
| Beth Seidenberg | 1 | 15 |
| Herrick Lau | 1 | 10 |
| Sean Parker | 1 | 10 |
| Judith Li | 1 | 8 |
| NITIN KAUSHAL | 1 | 8 |
| DENISE LOK | 1 | 8 |
| Michael Gray | 1 | 6 |
| SAVIO CHIU | 1 | 6 |
| David Velisek | 1 | 5 |
| Yan Zhang | 1 | 4 |
| DAVID FRENCH | 1 | 4 |
| Kathryn Walker | 1 | 4 |
| DAVID EATON | 1 | 4 |
| Garry Nicholson | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.